378 related articles for article (PubMed ID: 19615925)
1. Prolonged-release naloxone can cause systemic opioid withdrawal.
Wilcock A
Eur J Pain; 2009 Oct; 13(9):1001; author reply 1002-3. PubMed ID: 19615925
[No Abstract] [Full Text] [Related]
2. Opioid withdrawal syndrome after treatment with low-dose extended-release oxycodone and naloxone in a gastric cancer patient with portal vein thrombosis.
Kang JH; Lee GW; Shin SH; Bruera E
J Pain Symptom Manage; 2013 Aug; 46(2):e15-7. PubMed ID: 23680581
[No Abstract] [Full Text] [Related]
3. Oxycodone/naloxone preparation can cause acute withdrawal symptoms when misused parenterally or taken orally.
Wong A; Macleod D; Robinson J; Koutsogiannis Z; Graudins A; Greene SL
Clin Toxicol (Phila); 2015; 53(8):815-8. PubMed ID: 26109423
[TBL] [Abstract][Full Text] [Related]
4. Precipitated withdrawal during maintenance opioid blockade with extended release naltrexone.
Fishman M
Addiction; 2008 Aug; 103(8):1399-401. PubMed ID: 18855831
[TBL] [Abstract][Full Text] [Related]
5. Severe withdrawal from short-term transdermal fentanyl after naloxone for uremic pruritus.
Finsterer J; Keller H; Arias I; Zuntner G
J Pain Symptom Manage; 2004 May; 27(5):387-8. PubMed ID: 15120761
[No Abstract] [Full Text] [Related]
6. [Practical problems associated with long-term opioid therapy].
Bell RF
Tidsskr Nor Laegeforen; 1997 May; 117(12):1786-7. PubMed ID: 9213988
[TBL] [Abstract][Full Text] [Related]
7. New Formulation of Sustained Release Naloxone Can Reverse Opioid Induced Constipation Without Compromising the Desired Opioid Effects.
Sanders M; Jones S; Löwenstein O; Jansen JP; Miles H; Simpson K
Pain Med; 2015 Aug; 16(8):1540-50. PubMed ID: 26110375
[TBL] [Abstract][Full Text] [Related]
8. [Tolerated opioid therapy with oxycodone/naloxone. Better quality of life for osteoporosis patients].
MMW Fortschr Med; 2009 Apr; 151(18):27. PubMed ID: 19769067
[No Abstract] [Full Text] [Related]
9. Antagonist treatment of opioid withdrawal translational low dose approach.
Mannelli P; Gottheil E; Van Bockstaele EJ
J Addict Dis; 2006; 25(2):1-8. PubMed ID: 16785213
[TBL] [Abstract][Full Text] [Related]
10. The attractiveness of opposites: agonists and antagonists.
O'Brien T
J Pain Palliat Care Pharmacother; 2015 Mar; 29(1):67-9. PubMed ID: 25643224
[TBL] [Abstract][Full Text] [Related]
11. Quality of life and healthcare resource in patients receiving opioids for chronic pain: a review of the place of oxycodone/naloxone.
Morlion B; Clemens KE; Dunlop W
Clin Drug Investig; 2015 Jan; 35(1):1-11. PubMed ID: 25479959
[TBL] [Abstract][Full Text] [Related]
12. [Modern pain therapy with dual advantage. Strong analgesia and superior tolerance].
MMW Fortschr Med; 2009 Apr; 151(18):26. PubMed ID: 19769066
[No Abstract] [Full Text] [Related]
13. Withdrawal syndrome is not precipitated when butorphanol is added to opiate or opioid therapy. A comment on intranasal butorphanol-induced apraxia reversed by naloxone.
Barkin RL
Pharmacotherapy; 1996; 16(5):969. PubMed ID: 8888097
[No Abstract] [Full Text] [Related]
14. Assessment of the appropriateness of naloxone administration to patients receiving long-term opioid therapy.
Facey C; Brooks D; Boland JW
Hosp Pract (1995); 2016; 44(2):86-91. PubMed ID: 26837434
[TBL] [Abstract][Full Text] [Related]
15. Potential drug interaction with opioid agonist in the setting of chronic low-dose opioid antagonist use.
Leonard JB; Nair V; Diaz CJ; Penoyar JB; Goode PA
Am J Emerg Med; 2017 Aug; 35(8):1209.e3-1209.e4. PubMed ID: 28410920
[TBL] [Abstract][Full Text] [Related]
16. Effects associated with double-blind omission of buprenorphine/naloxone over a 98-h period.
Correia CJ; Walsh SL; Bigelow GE; Strain EC
Psychopharmacology (Berl); 2006 Dec; 189(3):297-306. PubMed ID: 17013637
[TBL] [Abstract][Full Text] [Related]
17. An investigation of the ability of oral naloxone to correct opioid-related constipation in patients with advanced cancer.
Sykes NP
Palliat Med; 1996 Apr; 10(2):135-44. PubMed ID: 8800821
[TBL] [Abstract][Full Text] [Related]
18. High doses of oxycodone-naloxone combination may provide poor analgesia.
Mercadante S; Ferrera P; Adile C
Support Care Cancer; 2011 Sep; 19(9):1471-2. PubMed ID: 21656338
[TBL] [Abstract][Full Text] [Related]
19. Overdose prevention: naloxone with long acting opioids.
Bowman S; McKenzie M; Rich J
Med Health R I; 2008 Sep; 91(9):271-2. PubMed ID: 18834043
[No Abstract] [Full Text] [Related]
20. [New study demonstrates dual effect of an oxycodone/naloxone combination. Strong pain palliation and preserving intestinal function].
MMW Fortschr Med; 2007 Nov; 149(48):50. PubMed ID: 18161439
[No Abstract] [Full Text] [Related]
[Next] [New Search]
